Frost & Sullivan releases 'Market Research Report on Microtubule Inhibitor Chemotherapy Drugs'

Based on research into the market for microtubule inhibitor chemotherapy drugs, Frost & Sullivan (Frost & Sullivan) hereby publishes the 'Microtubule Inhibitor Chemotherapy Drug Market Research Report'. The report includes six sections: analysis of the Chinese oncology drug market, the microtubule inhibitor drug market, the breast cancer market, the non-small cell lung cancer market, the gastric cancer market, and the esophageal cancer market.